Tumor Microenvironment in Ovarian Cancer
Study of the Role of the Tumor Microenvironment in Ovarian Cancer
University of Udine
50 participants
Jan 2, 2024
OBSERVATIONAL
Conditions
Summary
A detailed understanding of molecular mechanism of cancer genesis is fundamental to develop innovative and personalized therapies. The new frontier in biomedical research is represented by organoids, a three-dimensional cell culture system obtained from a tissue fragment that accurately reproduces the essential properties of the original tissue in vitro, which could provide a valuable model for explanation of ovarian cancers pathogenesis and will allow to predict the response to a specific therapy. With this research project, we expect to generate ovarian cancer organoids to characterize in vitro interactions and molecular pathway among tumor cells, immune cells, and resident microbiota (intratumoral bacteria and/or microbial-derived molecules).
Eligibility
Inclusion Criteria4
- Age \> 18 years
- Age \< 80 years
- Serous ovarian carcinoma
- FIGO Stage III-IV
Exclusion Criteria8
- Ongoing or suspended immunosuppressive therapy within the last 6 months
- Congenital or acquired immunodeficiency
- Immunosuppressive state
- Administration of chemotherapy for another neoplasm in the past 12 months
- Non-epithelial ovarian tumors
- Patients not undergoing surgical intervention
- BMI \> 30
- Absence of Informed Consent
Interventions
To characterize in vitro interactions and molecular pathway among tumor cells, immune cells, and resident microbiota (intratumoral bacteria and/or microbial-derived molecules)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06272240